Definium Therapeutics (NASDAQ:DFTX) Rating Increased to Hold at Wall Street ZenMarket Beat·1 day ago, 12:12 AMDFTX+0.56%
Is Definium Therapeutics (DFTX) Expensive As New GAD Study Sharpens Its Late Stage Case?Simplywall·Jul 23 at 12:07 PMDFTX+0.56%
Definium Therapeutics issues options for 30,330 shares to new hires under inducement planPUBT·Jul 20 at 03:01 PMDFTX+0.56%
Why Is GH Research Stock Trading Higher on Thursday?benzinga_article·Jul 16 at 11:36 AMGHRS-1.27%ATAI+0.14%
Definium Therapeutics climbs 7% to 52-week high on stock grant newsUS Stock Market Update·Jul 9 at 03:21 PMDFTX+0.56%
Definium Therapeutics climbs 5% to 52-week high after employee stock grantUS Stock Market Update·Jul 9 at 11:01 AMDFTX+0.56%
Definium Therapeutics Announces New Employee Inducement Grants | DFTX Stock NewsStockTitan·Jul 6 at 07:01 AMDFTX+0.56%
Top 3 Health Care Stocks That May Keep You Up At Night In Junebenzinga_article·Jun 30 at 07:55 AMGALT+0.58%DFTX+0.56%
Definium Therapeutics Sets $805 Million Public Offering at $34; Underwriting Agreement SignedTradingView·Jun 24 at 04:23 PMDFTX+0.56%
Definium Therapeutics Stock (DFTX) Soars on a Public Offering Pricing After Strong Trial ResultsTip Ranks·Jun 24 at 10:25 AMDFTX+0.56%
